Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



COLA MICHAEL F Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $56.1, valued at $561k
05/30/2023 4 COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
06/17/2022 4 COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.
Txns: Granted 9,947 options to buy @ $31.36, valued at $311.9k
05/27/2022 4 COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 15,000 options to buy @ $7.4, valued at $111k
02/18/2022 4 COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Bought 9,798 shares @ $19, valued at $186.2k
10/04/2021 4 COLA MICHAEL F (CEO) has filed a Form 4 on Avalo Therapeutics, Inc.
Txns: Granted 78,116 options to buy @ $2.25, valued at $175.8k
07/02/2021 4 COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.
Txns: Granted 51,740 options to buy @ $3.39, valued at $175.4k
06/11/2021 4 COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $76.09, valued at $760.9k
05/24/2021 4 COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 12,500 options to buy @ $35.49, valued at $443.6k
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/28/2021 4 COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.
Txns: Granted 850,000 options to buy @ $3.32, valued at $2.8M
01/06/2021 4 COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.
Txns: Granted 64,798 options to buy @ $2.64, valued at $171.1k
10/02/2020 4 COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.
Txns: Granted 76,674 options to buy @ $2.24, valued at $171.7k
07/06/2020 4 COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.
Txns: Granted 64,683 options to buy @ $2.56, valued at $165.6k
06/22/2020 4 COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.
Txns: Granted 84,322 options to buy @ $2.51, valued at $211.6k
06/11/2020 4 COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.
Txns: Bought 100,000 shares @ $2.5, valued at $250k
06/11/2020 4 COLA MICHAEL F (CEO) has filed a Form 4 on Aevi Genomic Medicine, LLC
Txns: Bought 100,000 shares @ $2.5, valued at $250k
06/11/2020 4 COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $36.47, valued at $364.7k
05/22/2020 4 COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 10,000 options @ $36.85, valued at $368.5k
02/05/2020 4 COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.
Txns: Granted 75,746 shares @ $0
Granted 1,200,000 options to buy @ $3.98, valued at $4.8M
02/05/2020 3 COLA MICHAEL F (CEO) has filed a Form 3 on Cerecor Inc.
02/05/2020 4 COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.
Txns: Disposed/sold 2,267,859 shares @ $0
Disposed/sold 17,327 options to buy @ $6.45, valued at $111.8k
Disposed/sold 292,087 options to buy @ $7.01, valued at $2M
Disposed/sold 250,000 options to buy @ $4.83, valued at $1.2M
Disposed/sold 250,000 options to buy @ $4.91, valued at $1.2M
Disposed/sold 450,000 options to buy @ $1.51, valued at $679.5k
Disposed/sold 661,000 options to buy @ $1.55, valued at $1M
Disposed/sold 50,000 options to buy @ $1.32, valued at $66k
Disposed/sold 1,500,000 options to buy @ $4.22, valued at $6.3M
Disposed/sold 21,181 warrants @ $2.84, valued at $60.2k
12/09/2019 4 COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.
Txns: Bought 2,049,376 shares @ $0.134, valued at $274.6k
10/24/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
06/17/2019 4 COLA MICHAEL F (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $15.04, valued at $150.4k
06/06/2019 4 COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $177.41, valued at $1.8M
06/18/2018 4 COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.
Txns: Granted 661,000 options to buy @ $1.55, valued at $1M
06/15/2018 4 COLA MICHAEL F (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $18.3, valued at $183k
06/08/2018 4 COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $154.06, valued at $1.5M
05/16/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/16/2018 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
10/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/19/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy